On the mechanism of the effect of acetylcholine on the pulmonary circulation

  • A. I. Khomazyuk
  • A. A. Moibenko
Physiology
  • 21 Downloads

Summary

It was shown in experiments on dogs that during the circulation through the pulmonary vascular system of acetylcholine added to the blood no recordable pressure changes were noted in the pulmonary circulation. Pressor reaction began in 4–11 seconds after the administration into the pulmonary artery. Injection of acetylcholine into the left ventricle and aorta also leads to the pressor reaction in the pulmonary circulation; this occurs earlier than when the substance is injected into the femoral vein or directly into the pulmonary artery (in 4 seconds). Besides, pressor reaction is more marked in administration of acetylcholine into the left ventricle and aorta than in injection into the venous part of the systemic circulation. Pressure reduction in the pulmonary artery, preceding its rise, is directly connected with the inhibition of the cardiac activity and is also well reproduced with acetylcholine administered into the pulmonary artery and the left ventricle of the heart.

Thus, acetylcholine does not provoke direct changes in the hemodynamics of the pulmonary circulation, and, evidently, does not influence the tone of the pulmonary vessels.

Period of reaction development in the pulmonary circulation and the same type of reaction occurring in acetylcholine administration into the venous and the arterial portion of the circulation lead to the conclusion that the hemodynamic effects the pulmonary circulation reflect the hemodynamic shifts in the systemic circulation.

Keywords

Pulmonary Artery Left Ventricle Acetylcholine Systemic Circulation Vascular System 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. 1.
    M. M. Lenkevich, Farmakol. i Toksikol.13, 4, 19 (1950).Google Scholar
  2. 2.
    A. I. Khomazyuk, in: Questions of Cardiovascular System Pathology [in Russian] (Kiev, 1959) p. 277.Google Scholar
  3. 3.
    H. G. Borst, E. Berglund, and M. McGregor, J. Clin. Invest.36, 669 (1957).Google Scholar
  4. 4.
    A. F. Cournand, Am. Heart J.54, 172 (1957).Google Scholar
  5. 5.
    R. Daley, Brit. Med. J.2, 249 (1957).Google Scholar
  6. 6.
    I. de B. Daly, Physiol. Rev.13, 149 (1933).Google Scholar
  7. 7.
    I. de B. Daly, et al., Quart. J. Exper. Physiol.27, 123 (1938).Google Scholar
  8. 8.
    I. de B. Daly and M. de B. Daly, J. Physiol.137, 427 (1957).Google Scholar
  9. 9.
    U. S. Euler and G. Liljestrand, Acta. Physiol. Scandinav.12, 301 (1946).Google Scholar
  10. 10.
    L. Friedberg, L. N. Katz, and F. S. Steinitz, J. Pharmacol. and Exper. Therap.77, 80 (1943).Google Scholar
  11. 11.
    J. H. Gaddum and P. Holtz, J. Physiol.77, 139 (1933).Google Scholar
  12. 12.
    V. Johnson, et al., Am. J. Physiol.120, 624 (1937).Google Scholar
  13. 13.
    P. Harris, Brit. Heart J.19, 272 (1957).Google Scholar
  14. 14.
    P. Harris, et al., Proc. Soc. Exper. Biol. and Med.93, 77 (1956).Google Scholar
  15. 15.
    S. Rodbard, Am. J. Med.15, 356 (1953).Google Scholar
  16. 16.
    J. C. Rose, Proc. Soc. Exper. Biol. and Med.94, 734 (1957).Google Scholar
  17. 17.
    D. J. Smith and J. W. Coxe, Am. J. Physiol.167, 732 (1951).Google Scholar
  18. 18.
    P. Wood, et al., Brit. Heart J.19, 279 (1957).Google Scholar

Copyright information

© Consultants Bureau Enterprises, Inc. 1961

Authors and Affiliations

  • A. I. Khomazyuk
    • 1
  • A. A. Moibenko
    • 1
  1. 1.Department of PathophysiologyAcademician N. D. Strazhesko Ukrainian Institute for Scientific Research in Clinical MedicineKiev

Personalised recommendations